Literature DB >> 36266666

Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016-2018.

Akash Gupta1, Fatma M Shebl2, Yao Tong2, Katherine Wagner3, Ingrid V Bassett2, Kimberly Page3, Erin L Winstanley4.   

Abstract

BACKGROUND: Injection drug use (IDU) remains the strongest risk factor for hepatitis C virus (HCV) in the United States. HCV rates are increasing in rural areas among young adult people who inject drugs (PWID). People with HCV and PWID have disproportionate rates of mental health problems; however, it is unclear whether risky injection behaviors mediate the association between mental health problems and HCV. We examined the association between mental health problems and HCV in a rural cohort of young adult PWID, with the goal of informing rural service delivery.
METHODS: We conducted a secondary analysis of cross-sectional data from a convenience sample of young adult PWID in 2 rural counties in New Mexico. Participants were recruited from 2 community venues between September 2016 and May 2018. Associations between mental health problems and HCV were examined using bivariate (Fisher's exact) and multivariable modified Poisson regression analyses (with robust standard errors). Using structural equation modeling (SEM), we assessed duration of IDU and receptive syringe sharing (RSS) as mediators of this relationship.
RESULTS: A total of 263 patients were enrolled, with a median age of 26.1 years. The majority were male (66.3%) and Hispanic/Latino (a) (87.6%). The median age first injected was 19 years, and over half reported having ever engaged in RSS (53.4%). At least one mental health problem was reported by 60.1% of participants, with post-traumatic stress disorder (PTSD) being the most prevalent condition (42.2%). A majority (60.9%) tested positive for HCV antibody, and just under half (45.7%) of all participants tested positive for HCV ribonucleic acid. In SEM, PTSD had a significant total effect on HCV (τ = 0.230, P = 0.05), and this relationship was partially mediated by duration of IDU (αβ = 0.077, P = 0.03). The association between mental health problems and HCV was partially mediated by duration of IDU and the sequential mediation of duration of IDU and RSS (αβ + αββ = 0.091, P = 0.05).
CONCLUSIONS: High HCV rates among young adult PWID in rural New Mexico may be partly explained by mental health problems, duration of IDU and RSS. Mental health services for young adult PWID in rural areas may help decrease HCV transmission in rural areas. Trial Registration N/A.
© 2022. The Author(s).

Entities:  

Keywords:  Hepatitis C; Injection drug use; Mental health; Opioid use disorder treatment; Post-traumatic; Stress disorders

Mesh:

Substances:

Year:  2022        PMID: 36266666      PMCID: PMC9583516          DOI: 10.1186/s13722-022-00340-3

Source DB:  PubMed          Journal:  Addict Sci Clin Pract        ISSN: 1940-0632


  51 in total

1.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

2.  Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.

Authors:  Lisa Maher; Bin Jalaludin; Kerry G Chant; Rohan Jayasuriya; Tim Sladden; John M Kaldor; Penny L Sargent
Journal:  Addiction       Date:  2006-10       Impact factor: 6.526

3.  County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Authors:  Michelle M Van Handel; Charles E Rose; Elaine J Hallisey; Jessica L Kolling; Jon E Zibbell; Brian Lewis; Michele K Bohm; Christopher M Jones; Barry E Flanagan; Azfar-E-Alam Siddiqi; Kashif Iqbal; Andrew L Dent; Jonathan H Mermin; Eugene McCray; John W Ward; John T Brooks
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

Review 4.  The link between substance abuse and posttraumatic stress disorder in women. A research review.

Authors:  L M Najavits; R D Weiss; S R Shaw
Journal:  Am J Addict       Date:  1997

5.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Philippe Bourgois; Ellen Stein; Jennifer L Evans; Michael P Busch; Leslie H Tobler; Bruce Phelps; Andrew R Moss
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

6.  Age at first injection and HIV risk among intravenous drug users.

Authors:  R J Battjes; C G Leukefeld; R W Pickens
Journal:  Am J Drug Alcohol Abuse       Date:  1992       Impact factor: 3.829

7.  Relationship among gender, depression, and needle sharing in a sample of injection drug users.

Authors:  Mark E Johnson; Michelle J Yep; Christiane Brems; Shelley A Theno; Dennis G Fisher
Journal:  Psychol Addict Behav       Date:  2002-12

8.  Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico.

Authors:  Katherine Wagner; Yuna Zhong; Eyasu Teshale; Kirsten White; Erin L Winstanley; Jennifer Hettema; Karla Thornton; Birgitta Bisztray; Philip Fiuty; Kimberly Page
Journal:  Drug Alcohol Depend       Date:  2021-01-11       Impact factor: 4.492

Review 9.  Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis.

Authors:  Elizabeth Hughes; Shaan Bassi; Simon Gilbody; Martin Bland; Fabiola Martin
Journal:  Lancet Psychiatry       Date:  2015-11-29       Impact factor: 27.083

10.  Associations Between Childhood Trauma and the Age of First-Time Drug Use in Methamphetamine-Dependent Patients.

Authors:  Cui Huang; Qiuyu Yuan; Ling Zhang; Lei Wang; Shu Cui; Kai Zhang; Xiaoqin Zhou
Journal:  Front Psychiatry       Date:  2021-03-26       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.